Epidemiology of triple negative breast cancers

Issue title: Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Guest editors: Jennifer Eng-Wongx and Jo Anne Zujewskiy

Article type: Research Article

Authors: Gierach, Gretchen L.^a | Burke, Aileen^a | Anderson, William F.^{b; *}

Affiliations: [a] Hormonal and Reproductive Epidemiology Branch, DHHS/NIH/NCI/Division of Cancer Epidemiology and Genetics (DCEG), Bethesda, MD, USA | [b] Biostatistics Branch, DHHS/NIH/NCI/Division of Cancer Epidemiology and Genetics (DCEG), Bethesda, MD, USA | [x] Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA | [y] Clinical Trial Evaluation Program (CTEP), National Cancer Institute, Bethesda MD, USA

Correspondence: [*] Corresponding author: William F. Anderson, Biostatistics Branch (BB), DHHS/NIH/ NCI/Division of Cancer Epidemiology and Genetics (DCEG), EPS, Room 8036, 6120 Executive Blvd, Bethesda, MD 20892-7244, USA. Tel.: +1 301 594 9125; Fax: +1 301 402 0081; E-mail: [email protected]

Keywords: Breast cancer, triple negative breast cancers, breast cancer molecular subtypes, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), breast cancer risk factors, breast cancer epidemiology

DOI: 10.3233/BD-2010-0319

Journal: Breast Disease, vol. 32, no. 1-2, pp. 5-24, 2011